CAAP Company: Conavi Medical Receives 510(k) Clearance for Foresight Intracardiac Echocardiography (ICE) System now Equipped with Color Doppler, 2D and 3D Measurements, and Enhanced 3D Visualization

Toronto, May 1 2017 Conavi Medical Inc. announced their 510(k) clearance from the FDA for its Foresight ICE System expanded feature set. The enhancements include color doppler, pulsed wave doppler, 2D and 3D measurements, and ECG-gated 3D image acquisition. These enhancements are expected to help electrophysiologists and interventional cardiologists in the US by providing them with the tools to make decisions during minimally invasive cardiovascular procedures.

"This system is the world's first intracardiac echo system with the capability to acquire 2D and 3D images with a broad field-of-view that includes both side-viewing and forward-looking capabilities. We have now expanded upon this foundation by adding image quality enhancements, features to minimize the effects of cardiac motion and the inclusion of additional imaging modes." says Dr. Brian Courtney, CEO of Conavi.

For the full press release click here